SYMPTOMATIC INCREASE IN INTRACRANIAL-PRESSURE FOLLOWING PANCREATIC-ENZYME REPLACEMENT THERAPY FOR CYSTIC-FIBROSIS

Authors
NASR SZ SCHAFFERT D
Citation
Sz. Nasr et D. Schaffert, SYMPTOMATIC INCREASE IN INTRACRANIAL-PRESSURE FOLLOWING PANCREATIC-ENZYME REPLACEMENT THERAPY FOR CYSTIC-FIBROSIS, Pediatric pulmonology, 19(6), 1995, pp. 396-397
Citations number
10
Categorie Soggetti
Respiratory System",Pediatrics
Journal title
Pediatric pulmonology → ACNP
ISSN journal
87556863
Volume
19
Issue
6
Year of publication
1995
Pages
396 - 397
Database
ISI
SICI code
8755-6863(1995)19:6<396:SIIIFP>2.0.ZU;2-Q
Abstract
A newly diagnosed 5-month-old infant with cystic fibrosis (CF) develop ed signs and symptoms of increased intracranial pressure (ICP) within days of starting pancreatic enzyme replacement therapy. Symptoms promp tly resolved on two occasions after stopping enzyme replacement. At 10 months of age, enzyme replacement was well tolerated. Pediatr Pulmono l, 1995; 19:395-397. (C) 1995 Wiley-Liss, Inc.